Dawn Halkuff, Director at Xeris Biopharma Holdings, Inc. (XERS), sold 20,000 shares at $6.09 ($122K) on 2026-06-04, disclosed to the SEC on 2026-06-05.
Scheduled sale ($122k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |